JPMorgan Chase & Co. Lowers Synthomer (LON:SYNT) Price Target to GBX 120

Key Points

• JPMorgan Chase & Co. has reduced the price target for Synthomer from GBX 200 to GBX 120, maintaining a "neutral" rating on the stock.
• Synthomer's latest trading price is GBX 66.23, showing a 1.4% decline during mid-day trading, with a 12-month high of GBX 189.80 and a low of GBX 56.58.
• Several analysts suggested a "hold" rating for Synthomer, with Jefferies Financial Group setting a target of GBX 100 and Berenberg Bank lowering theirs to GBX 80.

Synthomer (LON:SYNT - Get Free Report) had its price objective decreased by equities researchers at JPMorgan Chase & Co. from GBX 200 to GBX 120 in a report issued on Friday,Digital Look reports. The brokerage currently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s price target points to a potential upside of 81.18% from the company's current price.

Several other equities research analysts also recently issued reports on SYNT. Jefferies Financial Group reaffirmed a "hold" rating and set a GBX 100 price target on shares of Synthomer in a report on Tuesday, August 5th. Berenberg Bank dropped their price target on Synthomer from GBX 120 to GBX 80 and set a "hold" rating on the stock in a research note on Wednesday, August 6th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on Synthomer from GBX 140 to GBX 115 and set a "hold" rating on the stock in a research report on Wednesday, July 30th. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of GBX 103.75.

Synthomer Trading Down 1.4%

Shares of LON:SYNT traded down GBX 0.97 during mid-day trading on Friday, reaching GBX 66.23. The stock had a trading volume of 1,279,085 shares, compared to its average volume of 822,003. The firm has a market cap of £108.27 million, a PE ratio of -129.61, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The firm has a 50 day simple moving average of GBX 65.92 and a two-hundred day simple moving average of GBX 87.74. The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 78.27. Synthomer has a twelve month low of GBX 56.58 and a twelve month high of GBX 189.80.

Synthomer (LON:SYNT - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported GBX (5.40) earnings per share (EPS) for the quarter. Synthomer had a negative return on equity of 7.52% and a negative net margin of 4.40%. On average, research analysts predict that Synthomer will post 12.962963 EPS for the current fiscal year.

Insider Activity

In other Synthomer news, insider Jonathan Silver bought 59,229 shares of the business's stock in a transaction dated Wednesday, August 6th. The shares were purchased at an average price of GBX 65 per share, with a total value of £38,498.85. Also, insider Lily Liu acquired 20,000 shares of the firm's stock in a transaction dated Tuesday, August 5th. The shares were acquired at an average price of GBX 64 per share, with a total value of £12,800. Insiders have acquired 104,229 shares of company stock worth $6,729,885 over the last ninety days. Corporate insiders own 4.99% of the company's stock.

Synthomer Company Profile

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.